(19)
(11) EP 0 835 319 A1

(12)

(43) Date of publication:
15.04.1998 Bulletin 1998/16

(21) Application number: 96921006.0

(22) Date of filing: 28.06.1996
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 35/ 76( . )
A61K 48/ 00( . )
C07K 14/ 47( . )
C07K 19/ 00( . )
C12N 15/ 12( . )
A61K 31/ 70( . )
A61K 38/ 00( . )
A61P 35/ 00( . )
C07K 14/ 82( . )
C12N 5/ 10( . )
C12N 15/ 83( . )
(86) International application number:
PCT/GB1996/001560
(87) International publication number:
WO 1997/002354 (23.01.1997 Gazette 1997/05)
(84) Designated Contracting States:
AT BE CH DE DK FR GB IT LI NL SE

(30) Priority: 30.06.1995 GB 19950013342

(71) Applicant: MEDICAL RESEARCH COUNCIL
London W1N 4AL (GB)

(72) Inventor:
  • LaTHANGUE, Nicholas, Barrie University of Glasgow
    Davidson Bldg. Glasgow G12 8QQ (GB)

(74) Representative: Brasnett, Adrian Hugh, et al 
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1